what are glp-1 agonists Evolution of GLP‐1 Receptor for Diabetes Treatment GLP-1 receptor agonists for individualized

NICE guidance (NG28) recommends considering GLP-1 receptor agonists for adults with type 2 diabetes when glycaemic targets are not achieved with other therapies, particularly in those with established cardiovascular disease or at high cardiovascular risk

Early PsA may display nonspecific musculoskeletal symptoms, such as inflammatory arthralgia or morning stiffness, even in the absence of overt synovitis or radiographic erosions (12)

[DOI] [PMC free article] [PubMed] [Google Scholar] 146.Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, et al

Am J Hypertens

Improved blood sugar control (slower glucose spikes)

2020 doi: 10.1111/dom.14195